US: 800.298.5699
Int'l: +1.240.747.3093
 
Matching geography
Reports matching your search in:
 
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!
 

Pharmaceuticals Market Research Reports & Industry Analysis

  • Biopharmaceuticals (190)
  • Diseases & Conditions (3584)
  • Drug Delivery (174)
  • Therapeutic Area (5642)
  • Vaccines (590)
RSS Feeds

Pharmaceuticals Industry Research & Market Reports

< prev 1    3  4  5  6  7  8  9  10  
Diagnostic Markets for Women's Health (Pregnancy and Ovulation, Bone Density, Prenatal Screening, Ultrasound, Mammography, Pap Smear, Colposcopy, HPV, UTI, and Other Testing)
10/30/2014 | published by: Kalorama Information
... maternal-fetal medicine, as well as autoimmune disease and cystic fibrosis. At many clinics and practices focused on the health of women, a range of specialties are offered, which often results in a need for specific ...  |  read more...
USD 3,995
Hormone Refractory Breast Cancer Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014
11/21/2014 | published by: DelveInsight
... provides comprehensive insights about phase III pipeline drugs and marketed drugs across the indication. A key objective of the report is to establish the understanding for API Manufacturers for marketed and Phase III pipeline drugs ...  |  read more...
USD 2,000
Velmetia-Drug Insights,2014
11/21/2014 | published by: DelveInsight
... US, detailed clinical assessment of the drug, patent details, route of synthesis, competitive landscape, and analysis of sales performance during the forecast period (2011-2015). The report also includes SWOT analysis for the drug. This report ...  |  read more...
USD 1,000
Viktoza-Drug Insights,2014
11/21/2014 | published by: DelveInsight
... US, detailed clinical assessment of the drug, patent details, route of synthesis, competitive landscape, and analysis of sales performance during the forecast period (2011-2015). The report also includes SWOT analysis for the drug. This report ...  |  read more...
USD 1,000
Xeloda-Drug Insights,2014
11/21/2014 | published by: DelveInsight
... US, detailed clinical assessment of the drug, patent details, route of synthesis, competitive landscape, and analysis of sales performance during the forecast period (2011-2015). The report also includes SWOT analysis for the drug. This report ...  |  read more...
USD 1,000
EpiCast Report: Celiac Disease - Epidemiology Forecast to 2023
11/10/2014 | published by: GlobalData
... grains, such as wheat, rye, and barley. In celiac disease, the body’s immune system attacks and destroys the villi of the small intestine and thus interferes with nutrient absorption. Celiac disease can be difficult to ...  |  read more...
USD 3,995
Xeristar-API Insights, 2014
11/21/2014 | published by: DelveInsight
... number of blockbuster drugs going off patent in the coming years. It is going to affect the revenue of the API market as generic drugs occupy the market. India and China produce a large percentage ...  |  read more...
USD 500
Zarator-API Insights, 2014
11/21/2014 | published by: DelveInsight
... number of blockbuster drugs going off patent in the coming years. It is going to affect the revenue of the API market as generic drugs occupy the market. India and China produce a large percentage ...  |  read more...
USD 500
Singulair Paediatric-API Insights, 2014
11/21/2014 | published by: DelveInsight
... large number of blockbuster drugs going off patent in the coming years. It is going to affect the revenue of the API market as generic drugs occupy the market. India and China produce a large ...  |  read more...
USD 500
Nexium-Mups-API Insights, 2014
11/21/2014 | published by: DelveInsight
... number of blockbuster drugs going off patent in the coming years. It is going to affect the revenue of the API market as generic drugs occupy the market. India and China produce a large percentage ...  |  read more...
USD 500
Pritor-API Insights, 2014
11/21/2014 | published by: DelveInsight
... number of blockbuster drugs going off patent in the coming years. It is going to affect the revenue of the API market as generic drugs occupy the market. India and China produce a large percentage ...  |  read more...
USD 500
Alimta-API Insights, 2014
11/21/2014 | published by: DelveInsight
... number of blockbuster drugs going off patent in the coming years. It is going to affect the revenue of the API market as generic drugs occupy the market. India and China produce a large percentage ...  |  read more...
USD 500
Lovenox With Preservative-API Insights, 2014
11/21/2014 | published by: DelveInsight
... the large number of blockbuster drugs going off patent in the coming years. It is going to affect the revenue of the API market as generic drugs occupy the market. India and China produce a ...  |  read more...
USD 500
Velcade-API Insights, 2014
11/21/2014 | published by: DelveInsight
... number of blockbuster drugs going off patent in the coming years. It is going to affect the revenue of the API market as generic drugs occupy the market. India and China produce a large percentage ...  |  read more...
USD 500
Pariet -API Insights, 2014
11/21/2014 | published by: DelveInsight
... large number of blockbuster drugs going off patent in the coming years. It is going to affect the revenue of the API market as generic drugs occupy the market. India and China produce a large ...  |  read more...
USD 500
Tarceva-API Insights, 2014
11/21/2014 | published by: DelveInsight
... number of blockbuster drugs going off patent in the coming years. It is going to affect the revenue of the API market as generic drugs occupy the market. India and China produce a large percentage ...  |  read more...
USD 500
Seroquel-API Insights, 2014
11/21/2014 | published by: DelveInsight
... number of blockbuster drugs going off patent in the coming years. It is going to affect the revenue of the API market as generic drugs occupy the market. India and China produce a large percentage ...  |  read more...
USD 500
Zactos-API Insights, 2014
11/21/2014 | published by: DelveInsight
... number of blockbuster drugs going off patent in the coming years. It is going to affect the revenue of the API market as generic drugs occupy the market. India and China produce a large percentage ...  |  read more...
USD 500
Tracleer-API Insights, 2014
11/21/2014 | published by: DelveInsight
... number of blockbuster drugs going off patent in the coming years. It is going to affect the revenue of the API market as generic drugs occupy the market. India and China produce a large percentage ...  |  read more...
USD 500
Xeroquel LP-API Insights, 2014
11/21/2014 | published by: DelveInsight
... large number of blockbuster drugs going off patent in the coming years. It is going to affect the revenue of the API market as generic drugs occupy the market. India and China produce a large ...  |  read more...
USD 500
Eranz-API Insights, 2014
11/21/2014 | published by: DelveInsight
... number of blockbuster drugs going off patent in the coming years. It is going to affect the revenue of the API market as generic drugs occupy the market. India and China produce a large percentage ...  |  read more...
USD 500
Prezista-API Insights, 2014
11/21/2014 | published by: DelveInsight
... number of blockbuster drugs going off patent in the coming years. It is going to affect the revenue of the API market as generic drugs occupy the market. India and China produce a large percentage ...  |  read more...
USD 500
Baraklyud-API Insights, 2014
11/21/2014 | published by: DelveInsight
... number of blockbuster drugs going off patent in the coming years. It is going to affect the revenue of the API market as generic drugs occupy the market. India and China produce a large percentage ...  |  read more...
USD 500
Takepron-API Insights, 2014
11/21/2014 | published by: DelveInsight
... number of blockbuster drugs going off patent in the coming years. It is going to affect the revenue of the API market as generic drugs occupy the market. India and China produce a large percentage ...  |  read more...
USD 500
Zometa Concentrate-API Insights, 2014
11/21/2014 | published by: DelveInsight
... large number of blockbuster drugs going off patent in the coming years. It is going to affect the revenue of the API market as generic drugs occupy the market. India and China produce a large ...  |  read more...
USD 500
< prev 1    3  4  5  6  7  8  9  10